Analyst Ratings February 4, 2026

Cantor Fitzgerald Lifts Teradyne Price Target to $330, Citing AI-Driven Revenue Shift

Analyst upgrades valuation after Teradyne's strong guide for Q1 2026 and a deepening move into AI-related test equipment

By Derek Hwang TER
Cantor Fitzgerald Lifts Teradyne Price Target to $330, Citing AI-Driven Revenue Shift
TER

Cantor Fitzgerald increased its price objective for Teradyne to $330 from $270 and kept an Overweight rating after the company issued a robust guide for the first quarter of 2026. The firm pointed to Teradyne's accelerating pivot into artificial intelligence - which made up more than 60% of revenue in Q4 2025 and is expected to exceed 70% in Q1 2026 - as a key driver. The upgrade follows strong bookings, an improved backlog, and updated long-term financial targets, though analysts note valuation and revenue seasonality risks.

Key Points

  • Cantor Fitzgerald raised its Teradyne price target to $330 from $270 and maintained an Overweight rating.
  • AI-related products comprised over 60% of Teradyne's revenue in Q4 2025 and are expected to exceed 70% in Q1 2026, driving strong bookings and backlog.
  • Teradyne updated long-term targets to $9.25-11.00 in EPS and a 15-25% revenue CAGR while warning of revenue lumpiness across 2026.

Cantor Fitzgerald on Wednesday raised its price target for Teradyne (NASDAQ:TER) to $330.00 from $270.00 while retaining an Overweight rating on the stock. Teradyne shares were trading at $272.10 at the time, a level Cantor said still implies roughly 21% upside to its new target. InvestingPro data referenced by market observers also shows the stock trading well above its Fair Value and carrying a price-to-earnings ratio of 81.5.

The brokerage firm attributed the upward revision to what it described as a "blow out guide" for Teradyne's first quarter of 2026. Cantor highlighted a material shift in the company's revenue mix toward artificial intelligence-related products and services. In the fourth quarter of 2025, AI-related business represented over 60% of Teradyne's total revenues, and Cantor expects that proportion to climb to more than 70% in the first quarter of 2026. That change in mix has coincided with a pronounced rally in the stock, which returned 154.51% over the past year.

Teradyne has also revised its long-term planning assumptions, updating a target model that envisions diluted earnings per share in the range of $9.25 to $11.00 over time. Those EPS targets underpin a long-term revenue compound annual growth rate objective between 15% and 25%. The company reported diluted EPS of $3.47 recently, while consensus analyst projections point to $5.27 in EPS for fiscal year 2026. Cantor described near-term visibility as strong, citing healthy bookings and an improved backlog relative to the same point a year earlier.

Management cautioned, however, that revenue will likely be uneven through 2026. Cantor noted that Teradyne expects a first-half concentration of revenue followed by meaningful declines in the second half, effectively reversing the 58%/42% first-half/second-half mix the company experienced in 2025. The firm also flagged several potential growth catalysts and sources of demand for Teradyne's test equipment, including the prospect of capturing Nvidia share related to Rubin in the second half of 2026, stronger contributions from DRAM and HBM memory testing, and newly secured business with Seagate and Toshiba in the hard disk drive market.

Other brokerage reactions and company developments have accompanied the recent guidance. Cantor Fitzgerald's note on the results also described a "significant beat and raise" in EPS projections and reiterated an Overweight stance while previously citing a $270 price target. Stifel separately moved its own price objective to $325 and maintained a Buy rating, pointing to the momentum in AI applications that now account for more than 70% of Teradyne's semiconductor test business according to that firm's read. By contrast, Northland downgraded Teradyne from Outperform to Market Perform, explicitly calling out valuation concerns despite the company's solid results.

Beyond analyst coverage, Teradyne disclosed a strategic partnership to bolster its data center testing capabilities. The company announced a joint venture with MultiLane to create MultiLane Test Products, or MLTP, aimed at developing test solutions for high-speed data connections used in AI data centers. The transaction is expected to close in the first half of 2026, with Teradyne holding a majority ownership stake and MultiLane retaining a minority position. Cantor and others view the JV as consistent with Teradyne's emphasis on expanding its footprint in AI and data center test infrastructure.

Teradyne's recent quarterly results and forward guidance were characterized by significant contributions from AI-related business segments, a development that underpins the optimism from several sell-side firms. At the same time, some analysts continue to signal caution over valuation metrics and the possibility of revenue volatility within the year. For investors seeking deeper modeling and valuation context, InvestingPro provides research and a Fair Value calculator that aggregates multiple industry valuation approaches to assess whether Teradyne represents a bargain at prevailing prices.


What this means for markets

  • Semiconductor equipment and test markets are drawing investor attention as AI-related demand reshapes vendor revenue mixes.
  • Memory and data center infrastructure suppliers, including DRAM/HBM and HDD testing segments, stand to affect equipment order books and supplier backlogs.
  • Valuation dynamics in high-growth semiconductor suppliers remain a focal point for analysts and investors amid aggressive revenue and margin assumptions.

Risks

  • Valuation risk: the stock trades meaningfully above Fair Value with a P/E of 81.5, prompting concerns from some analysts.
  • Revenue seasonality and lumpiness: management expects a first-half revenue peak in 2026 followed by notable second-half declines, reversing 2025's mix.
  • Execution and market share uncertainty: potential wins such as securing NVIDIA share with Rubin and contributions from DRAM/HBM are cited as opportunities but carry execution risk.

More from Analyst Ratings

UBS trims TransDigm price target slightly to $1,800, keeps Buy as aftermarket growth cools Feb 4, 2026 UBS Holds Neutral on Electronic Arts as Battlefield 6 Boosts Quarterly Results Feb 4, 2026 UBS Raises DaVita Target to $190, Cites Elevated 2026 EPS Outlook Feb 4, 2026 UBS Boosts FedEx Price Target to $412, Cites Pricing Levers and Cost Cuts Feb 4, 2026 DA Davidson Lifts Almonty Industries Price Target to $18 as Tungsten Dynamics Shift Feb 4, 2026